LATEST ALERTS
British American Tobacco (BAT) saw revenue from its new products category portfolio rise by 42.4% in 2021 to £2.05bn, driven in part by an increase in sales of its modern oral products
Japan Tobacco International (JTI) will look to prioritise heated tobacco as part of its commitment to break even on its reduced risk portfolio (RRP) by 2027
Philip Morris International (PMI) posted positive numbers for 2021, helped by higher unit volumes in heated tobacco and outstanding initial results from its fourth-generation heated tobacco device Iqos Iluma
Approval of applications to sell new nicotine products in Norway appears to be a difficult proposition, according to Swedish Match, which had its application for an oral nicotine pouch rejected
Tobacco giant Altria’s net revenues slightly declined in 2021, partially offset by growth in the company’s oral tobacco products segment
Philip Morris’s bid to resume importing and selling its Iqos heat-not-burn (HnB) device in the US has failed
2021 may have been a downer in many other areas but the year saw phenomenal growth across tobacco alternatives, including in the oral segment, heated tobacco and nicotine pouches
The US FDA’s marketing authorisation of two low-nicotine cigarettes as modified risk tobacco products – including a menthol cigarette – has not gone down well with public health associations or all harm reduction experts
It’s the end of an era as tobacco sponsorship of Formula One racing comes to an end – again. Or does it and is it?
Tobacco giant Imperial Brands has told investors that the ongoing trials of its Pulze heated tobacco device and iD consumables in Central and Eastern Europe were “progressing well”
Altria posted a 4.7% revenue decline in the third quarter of the year, mainly driven by the continuing poor performance of its smokable segment but neutralised by the growth of its oral products in the US
The US Food and Drug Administration (FDA) has issued marketing authorisation for four mint-flavoured oral tobacco products that were withdrawn from the US market in 2019
Tobacco corporations seem to be accelerating their commitment towards more sustainable businesses, investing in projects to reduce environmental harm caused by tobacco-alternative devices
Philip Morris International (PMI) has concluded its controversial £1.1bn takeover of UK health firm Vectura, along with that of the Danish oral-products manufacturer Fertin Pharma
Swedish Match has announced that the company is to become 100% smoke-free by next year with the separation of its cigar business in the US, a decision that is likely to have an impact in the market
The board of UK health firm Vectura has recommended that shareholders support the £1.2bn takeover bid from tobacco giant PMI
The proposal of Philip Morris International (PMI) to acquire inhaled drug delivery company Ventura for $1.2bn has alerted the UK government, which can block the deal if it sees any major public interest reason to do so
JTI posted positive numbers in the first half of the year, with good performance from its reduced-risk products and improvement in its full-year guidance after the launch of Ploom X
Jacek Olczak, CEO of Philip Morris International (PMI), says the company could stop selling combustible cigarettes in the UK within a decade
British American Tobacco (BAT) has posted a 0.8% global decrease in revenue for the first half of the year, while the performance of its new category portfolio rose by 40.4%
The latest figures from Swedish Match show continued momentum in smoke-free tobacco alternatives, with nicotine pouches “the driving force”
Philip Morris International (PMI) has always been one of the frankest tobacco companies when it comes to speaking of the smoke-free future – now it is taking positive steps in a bold new direction
PMI’s acquisition of Fertin Pharma, a Danish manufacturer of gums and other oral products, indicates the company’s strategy to ensure “corporate survival” in the tobacco-alternatives sector, experts believe
British American Tobacco (BAT) is removing its Velo nicotine pouches from the German market because of a lack of clarity over their regulation both nationally and in the country’s regional states
Italy’s antitrust regulator has opened formal procedures against British American Tobacco (BAT) for using influencers to promote an advertising campaign for Glo Hyper, and it could cost the manufacturer millions
Imperial Brands’ earnings in the first half of the year jumped 6.1% to £15.57bn in the midst of a process to implement a new company strategy towards tobacco alternatives
Imperial Brands has announced that it expects to deliver its yearly objectives for 2021 and expressed optimism about the performance of its heated tobacco device Pulze
PMI is spreading optimism about its “beyond nicotine” portfolio, aiming to reach $1bn revenue from tobacco-alternatives in less than five years’ time, with an expected increase in the demand of heated tobacco consumables
Altria has posted positive numbers for the last quarter of 2020 despite the coronavirus pandemic, with a good performance for its oral portfolio but unknown figures for Iqos in the US
Imperial Brands has announced a substantial shift in strategy towards its next-generation products category, with a focus on investment in heated tobacco in Europe over the next five years
Philip Morris International (PMI) is to have a new CEO, with Jacek Olczak taking over from André Calantzopoulos after the annual shareholder meeting in May
Apart from the obvious, what has 2020 brought us? And in particular, what has it brought to the world of alternative tobacco and tobacco alternatives?
British American Tobacco (BAT) is planning to invest up to $25m in a factory in Kenya to manufacture Lyft nicotine pouches – under regulatory scrutiny from officials in the country
The US Food and Drug Administration (FDA) has issued a marketing order authorising the sale of Philip Morris International (PMI)’s IQOS 3 holder and charger
Imperial Brands has revealed that net revenue from its next-generation portfolio declined by 27% in the year to September and announced that it will take a “more prudent approach” from now on
Altria’s oral tobacco portfolio drove the numbers of the Big Tobacco company, amid “uncertainties” caused by the COVID-19 pandemic
While Philip Morris International (PMI)’s earnings fell slightly in the third quarter of the year due to the ongoing COVID-19 challenges, shipments of the company’s heated tobacco units were up by 18.7%
Imperial Brands has revealed that the company’s net revenue for its next-generation portfolio is around 30% lower than 2019, while the overall company revenue looks set to remain flat this year
While the Philippines debates regulations to restrict tobacco alternatives, PMFTC, the Philippine affiliate of Philip Morris International (PMI), has opened its first four IQOS stores in the Manila area
Reynolds American has submitted a premarket tobacco product application (PMTA) to the US Food and Drug Administration (FDA) for its Velo nicotine lozenges to remain on the market after September
KT&G heated tobacco products are available outside South Korea for the first time after Philip Morris International (PMI) began marketing them in Russia
Japan Tobacco International (JTI) is to increase the price of some of its heated tobacco consumables in Japan from 1st October
BAT’s revenue from its smokeless portfolio increased by 5.7% to £9.4bn ($12.3bn) in the first six months of the year, helped by higher revenue in the modern oral segment
Altria has reported net revenue to be down by 3.8% in Q2 2020 due to the decrease of the traditional tobacco business, though a further drop was prevented thanks to the good performance of its smokeless products in the US
The Japanese Consumer Affairs Agency has imposed a fine of JPY552m ($5.1m) on Philip Morris Japan (PMJ) for misleading advertising of Iqos when discounts were extended beyond the allotted date
This report covers the US role as a modern oral tobacco product player, examining snus, tobacco-free nicotine pouches and all-free products
British American Tobacco (BAT) is pushing back to 2025 its goal of £5bn in revenues from its next-generation portfolio amid the COVID-19 pandemic and a decrease in heat-not-burn (HnB) business
The Altria Group has filed a lawsuit for patent infringement against RJ Reynolds Vapor Co, a subsidiary of Reynolds American, over its Velo smokeless product
Japan Tobacco (JT) and Philip Morris International (PMI) are cutting the prices of their heat-not-burn (HnB) devices in Japan and planning new product launches amid the coronavirus pandemic
Altria has submitted premarket tobacco product applications (PMTAs) to the US Food and Drug Administration (FDA) for 35 varieties of its On! nicotine pouches
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of FREE platform access: Demo our data contents without commitment
"*" indicates required fields
